The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of immune checkpoint inhibitors as first line therapy for untreated, unresectable pleural mesothelioma: A systematic review and meta-analysis of randomized controlled trials.
 
Bibi Maryam
No Relationships to Disclose
 
Adolfo Diaz Barba
No Relationships to Disclose
 
Mohammad Jamil
No Relationships to Disclose
 
Muhammad Asif
No Relationships to Disclose
 
Bilqees Khanam
No Relationships to Disclose
 
Abdul Manaf
No Relationships to Disclose
 
Kalaivani Babu
No Relationships to Disclose
 
Srinishant Rajarajan
No Relationships to Disclose
 
Ryan Nipp
No Relationships to Disclose
 
Raid Aljumaily
Research Funding - Abbvie (Inst); Alliance Foundation Trials (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Baxalta (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Checkpoint Therapeutics (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Huntsman Cancer Institute (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Roche (Inst); Syneos Health (Inst); Tesaro (Inst)